Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million

/PRNewswire/ -- Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal's investigational medicine...

Related Keywords

Germany ,South Africa ,Japan ,United States ,America ,Gabriel Baertschi ,Florian Dieckmann ,Christopher Jansen ,Instagram ,Linkedin ,Shionogi Co Ltd ,National Institute Of Arthritis ,Route Of Administration Parenteral ,Chief Executive Officer ,Transient Receptor Potential Vanilloid ,Latin America ,Global Burden ,Disease Study ,Andmarkets Report ,Osteoarthritis Therapeutics Market ,Drug Type ,Distribution Channel ,Hospital Pharmacies ,Purchasing Pattern ,Prescription Drugs ,Skin Diseases ,What Causes Osteoarthritis ,Grünenthal Group ,